GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) effectively manage type 2 diabetes and promote weight loss, but their gastrointestinal effectsincluding nausea, vomiting, and diarrheacan disrupt fluid and electrolyte balance
The researchers note that both treatments are effective, but stress that there is not enough scientific knowledge on younger patients combining the two or sequentially using them
Long-term changes in bone density and bone metabolism after gastric bypass surgery: a retrospective cohort study
GLP-1 medications work by increasing feelings of fullness and decreasing your appetite, so if you miss a dose, you may notice an increase in hunger or food noise
These benefits generally result in improved blood sugar control and weight loss benefits
There is a notable lack of data regarding ipamorelins clinical effects in humans